Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for functional dyspepsia
ChiCTR2100048304Phase 4Not yet recruiting
- Sponsor
- Zibo City Central Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mirtazapine in functional dyspepsia (FD) (2 arms), sponsored by Zibo City Central Hospital. Primary endpoints: Total dyspepsia symptom score, Postprandial fullness and 2 more. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
mirtazapine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2100048304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048304.